Emergence of blaNDM-5-producing Escherichia coli ST410 in Companion Dogs Treated with Meropenem
Author(s) -
Jy Oh
Publication year - 2020
Publication title -
pakistan veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.281
H-Index - 29
eISSN - 2074-7764
pISSN - 0253-8318
DOI - 10.29261/pakvetj/2020.073
Subject(s) - meropenem , escherichia coli , biology , microbiology and biotechnology , plasmid , enterobacteriaceae , carbapenem , pulsed field gel electrophoresis , carbapenem resistant enterobacteriaceae , antibiotics , gene , antibiotic resistance , genotype , genetics
Carbapenem-resistant Escherichia coli (CRE) with a multidrug resistant phenotype was isolated from four clinically ill dogs treated with meropenem in different local animal hospitals between 2017 and 2019. IncX3-type plasmids of ca. 46 kb in size carrying blaNDM-5 were present in all CRE strains and their transconjugants. High genetic similarity (>90%) by PFGE analysis was observed among the CRE strains, which were identified as ST410.To the best of our knowledge, blaNDM-5-producing E. coli ST410 clones are emerging sporadically in companion dogs treated with meropenem. The spread of Enterobacteriaceae harboring the NDM-5 gene in companion animals can pose a threat to public health; therefore, extensive monitoring in veterinary hospitals using carbapenem and careful antibiotic use are crucial for managing and monitoring these resistant strains
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom